2014
DOI: 10.1161/atvb.34.suppl_1.457
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 457: Sulforaphane at Physiological Concentrations Inhibits TNF-α-Induced Monocyte Adhesion to Human Vascular Endothelial Cells and Improves Vascular Inflammation in Mice Through a Nuclear Factor-κB--Mediated Mechanism

Abstract: Introduction: TNF-α, plays an important role in endothelial dysfunction and is involved in the pathogenesis of atherosclerosis. Aim: We investigated the protective effect of cruciferous vegetable phytochemical sulforaphane at physiological concentrations on TNF-α-induced vascular inflammation. Methods: Human umbilical vascular endothelial cells (HUVEC) were pretreated with sulforaphane (0.5 - 8 μM) before ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Inflammation associated with diabetes in mice has been effectively ameliorated by sulforaphane, as shown in high-fat diet- or STZ-induced diabetes and cardiomyopathy [ 200 , 201 ], db / db diabetic mice cardiomyopathy [ 202 ], diabetic cardiomyopathy in both type 1 and type 2 diabetes [ 203 , 204 ], high-fat diet-induced diabetes [ 205 , 206 ], ob/ob diabetic mice [ 90 ], obesity- and type 2 diabetes-associated pain [ 207 ], STZ-induced diabetes [ 208 , 209 ], STZ-induced diabetic nephropathy [ 210 ], type 1 diabetic OVE26 mice [ 211 ], and diabetes-induced vascular inflammation and pathogenesis [ 212 ]. Using a high-fat diet model, the anti-inflammatory effects of sulforaphane in mice have been further shown in [ 213 , 214 ] as well as in American diet-induced inflammation [ 215 ], TNF-α-induced vascular inflammation [ 121 , 122 ], and high-fat diet-induced obesity [ 196 ] models.…”
Section: Anti-inflammatory Effects In Vivomentioning
confidence: 99%
See 4 more Smart Citations
“…Inflammation associated with diabetes in mice has been effectively ameliorated by sulforaphane, as shown in high-fat diet- or STZ-induced diabetes and cardiomyopathy [ 200 , 201 ], db / db diabetic mice cardiomyopathy [ 202 ], diabetic cardiomyopathy in both type 1 and type 2 diabetes [ 203 , 204 ], high-fat diet-induced diabetes [ 205 , 206 ], ob/ob diabetic mice [ 90 ], obesity- and type 2 diabetes-associated pain [ 207 ], STZ-induced diabetes [ 208 , 209 ], STZ-induced diabetic nephropathy [ 210 ], type 1 diabetic OVE26 mice [ 211 ], and diabetes-induced vascular inflammation and pathogenesis [ 212 ]. Using a high-fat diet model, the anti-inflammatory effects of sulforaphane in mice have been further shown in [ 213 , 214 ] as well as in American diet-induced inflammation [ 215 ], TNF-α-induced vascular inflammation [ 121 , 122 ], and high-fat diet-induced obesity [ 196 ] models.…”
Section: Anti-inflammatory Effects In Vivomentioning
confidence: 99%
“…Similarly, sulforaphane has been shown to suppress the expression of pro-inflammatory cytokines in microglial BV2 cells [ 103 , 110 , 113 , 115 ], N9 murine microglial cells [ 105 ], senescent astrocytes [ 108 ], primary co-cultures of rat microglial and astroglial cells [ 111 ], and Müller cells of the retina [ 51 ]. Other inflammation models in vitro where cytokine production has been suppressed by sulforaphane include mast cells [ 102 ], endothelial cells such as human umbilical vein endothelial cells (HUVECs) [ 121 , 122 ], saphenous vein endothelial cell [ 127 ], and transformed endothelial cells such as ECV304 [ 124 ]. Similarly, the upregulation of cytokines’ production in epithelial cells has been shown to be suppressed by sulforaphane, including in Caco-2 [ 135 ], human lung epithelial cells (BEAS-2B) [ 136 , 143 , 145 ], and primary mouse tracheal and human bronchial epithelial cells [ 139 ].…”
Section: Anti-inflammatory Studies In Vitromentioning
confidence: 99%
See 3 more Smart Citations